Intravitreal injections: taking the plunge
29 October 2021
Autumn 2021
Increasing demand for intravitreal injections to treat conditions such as wet AMD provides an opportunity for optometrists to widen their portfolio of skills, writes Kim Thomas.
Part of the success of the COVID-19 vaccination programme was down to the many optometrists and other healthcare professionals who helped deliver the vaccine. Now the programme is nearing its end, could optometrists use their newly acquired skills to take on another role – that of intravitreal injector?
Not already a member of the College?
Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.
Related further reading
Our Clinical Adviser comments on the story in the BBC about the woman who had gene therapy to try to halt the progression of age-related macular degeneration (AMD).
Our Clinical Adviser offers his advice, following an article by The Express on the best supplements for eyes.
This narrative review summarises emerging interventions that may be mentioned in the popular and professional press, and may be on our menu of treatment options to discuss with patients in the near future.